Caring for Patients with Mesothelioma: Principles and Guidelines

  • Mary Hesdorffer
  • Gleneara E. Bates-Pappas

Table of contents

  1. Front Matter
    Pages i-x
  2. Mesothelioma Treatment

  3. Therapeutic Treatments: Chemotherapy, Biotherapy, and Immunotherapy

    1. Front Matter
      Pages 57-57
    2. Mary Hesdorffer, Gleneara E. Bates-Pappas
      Pages 59-64
  4. Supportive Health Care for Treatment

    1. Front Matter
      Pages 89-89
    2. Richard D. Hemingway
      Pages 99-119
    3. Rodney Hemingway
      Pages 121-138
    4. Schuyler Cunningham, Hunter Groninger
      Pages 143-156
    5. Jadmin L. Mostel, Gleneara E. Bates-Pappas
      Pages 157-161
    6. Karlynn BrintzenhofeSzoc, Louisa Daratsos
      Pages 163-175
  5. Public Health Impact of Asbestos Worldwide

    1. Front Matter
      Pages 177-177
    2. Jadmin L. Mostel, Gleneara E. Bates-Pappas, Gregory Pappas
      Pages 179-183
  6. The Future of Mesothelioma Research

    1. Front Matter
      Pages 185-185
    2. Aaron Mansfield, Dennis Wigle, Tobias Peikert
      Pages 187-202
    3. Vanessa S. Fear, Alistair M. Cook, Scott A. Fisher
      Pages 203-227
  7. Patient’s Perspective

    1. Front Matter
      Pages 229-229
    2. Raya Bodnarchuk
      Pages 235-238
  8. Back Matter
    Pages 239-239

About this book


This book encompasses all areas for mesothelioma care, treatment, and research. Using nurses, social workers, surgeons, oncologist, radiologist and pain specialist to give the reader a comprehensive overview of mesothelioma treatment.   
Indeed, mesothelioma is a cancer that mainly affects the pleura and peritoneum, usually caused by exposure to asbestos. The number of individuals diagnosed with mesothelioma is increasing world-wide, particularly in developing countries where the use of asbestos remains uncontrolled. In spite of advances in chemotherapy, radiotherapy, and surgical approaches, mesothelioma remains resistant to treatment. According to the International Mesothelioma Interest group, overall survival has not improved; median survival times vary from one month to eighteen months. A small number of patients remain asymptomatic or with minimal symptoms for extended periods, and fewer live three years or more. Mesothelioma is often associated with difficult, intractable symptoms, particularly pain and difficulty breathing. Especially poor prognoses have been reported for those diagnosed with sarcomatoid rather than epithelioid histology, or with advanced disease, poor performance status, or pain and loss of appetite. Despite substantial progress of the last two decades improving the quality of life of patients with cancer, many mesothelioma patients still experience physical, psychological, social, and financial burdens. The development of multimodality treatment and mesothelioma centers has given renewed hope to patients. This book serves as a unique tool for medical professional while providing care for mesothelioma patients.


Long-term care Radiation therapy Chemothary End of life care Pallative care

Editors and affiliations

  • Mary Hesdorffer
    • 1
  • Gleneara E. Bates-Pappas
    • 2
  1. 1.Mesothelioma Applied Research FoundationAlexandriaUSA
  2. 2.City University of New York, Graduate CenterNew YorkUSA

Bibliographic information

  • DOI
  • Copyright Information Springer Nature Switzerland AG 2019
  • Publisher Name Springer, Cham
  • eBook Packages Medicine
  • Print ISBN 978-3-319-96243-6
  • Online ISBN 978-3-319-96244-3
  • Buy this book on publisher's site
Industry Sectors
Health & Hospitals